ASEAN health care still shine? Singapore based private equity, Quadria, says “Brutal”

English: The flags of Association of Southeast...

English: The flags of Association of Southeast Asia Nations (ASEAN) members in ASEAN headquarter at Jalan Sisingamangaraja No.70A, South Jakarta, Indonesia. From left the flags of: Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam. (Photo credit: Wikipedia)

ASEAN has been known a global hub for medical tourism. Within that environment, many health care start-up got its birth, growth and maturity, often with the help of private equity firm. But has the ASEAN medical and health care scene, lost its shine? Private Equity International reports, “Healthcare-focused firm Quadria Capital has reached a first close on $107 million for its second fund, according to a firm statement. Fund II was launched in 2012 and is targeting $300 million, according to PEI’s Research & Analytics division. The fund is targeting growth equity investments in scalable mid-sized healthcare companies in South and Southeast Asia, with a deal size of $20 million – $60 million. Quadria focuses on four sub-sectors: healthcare delivery, life sciences, medical technology, and healthcare services. “The fundraising environment is brutal,” said the firm executive. Sixty percent of Fund II will be invested in Southeast Asia, the rest in South Asia, mainly India. LPs questions have centered around the weakening macro-environment in India, currency depreciation in India and Indonesia, and the general slowdown in fund divestments, particularly in India, said the firm excecutive. “Having said that, we believe the market is sophisticated, and savvy LPs are still not moving away from the basics of investing. We have consistently said that the time has come for Asian funds to have specificity, and that healthcare will continue to grow despite the macro doom and gloom we’re hearing about.” LPs include the International Finance Corp, India-based financial services firm Religare Enterprises, Malaysia-based Goldis and Medtronic, a global medical device developer, which will commit to the fund with capital from its balance sheet, according to Varma. (Read More)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s